Marvell (MRVL) PT Raised to $29 at Cowen Following Cavium Deal; 'Organic Growth Plus Highly Synergistic Deal'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts MRVL Hot Sheet
Price: $244.04 +1.51%
Rating Summary:
51 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 13
Rating Summary:
51 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 13
Join SI Premium – FREE
Cowen raised its price target on Marvell (NASDAQ: MRVL) to $29.00 (from $21.00) while maintaining a Outperform rating, following the company's recent announcement to acquire Cavium for $6 billion.
Analyst Karl Ackerman notes a positive outlook on the shares, following management's recent announcement to acquire Cavium for $6 billion, suggesting this transaction represents the next phase of the story to execution of $2 per share in EPS in 2019 with Cavium in place.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) PT Raised to $260 at Pivotal Research
- 3M (MMM) PT Raised to $197 at Bernstein SocGen Group
- Intuitive Surgical (ISRG) PT Lowered to $550 at RBC Capital
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Cowen & Co, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
